Xarostat 40 Tablet contains Rosuvastatin 40 mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby decreasing cholesterol production in the liver and promoting increased clearance of LDL particles from the bloodstream. Xarostat 40 is prescribed as part of a comprehensive management plan including diet, exercise, and lifestyle modifications to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and angina in patients with atherosclerotic cardiovascular disease or multiple risk factors. The 40 mg dosage is typically reserved for patients requiring significant LDL-C reduction and should be used under close medical supervision due to the potential risk of adverse effects such as myopathy, liver enzyme elevation, and rare cases of rhabdomyolysis. Regular monitoring of lipid profiles, liver function tests, and creatine kinase levels is recommended during therapy to ensure safety and efficacy.